Condom and oral contraceptive use and risk of cervical intraepithelial neoplasia in Australian women

다국어 초록 (Multilingual Abstract)

Objective: To assess the association between condom use and oral contraceptive consumption and the risk of cervical intraepithelial neoplasia (CIN).
Methods: A cross-sectional study was conducted in Perth clinics. A total of 348 women responded to the structured questionnaire. Information sought included demographic and lifestyle characteristics such as the use of condom for contraception, consumption of oral contraceptive, and duration of oral contraceptive usage. Crude and adjusted odds ratio (OR) and associated 95% confidence interval (CI) were calculated using unconditional logistic regression models and reported as estimates of the relative risk.
Results: The prevalence of CIN was found to be 15.8%. The duration of oral contraceptive consumption among women with abnormal Papanicolaou (Pap) smear result indicating CIN was significantly shorter than those without abnormal Pap smear result (mean±SD, 5.6±5.2 years vs. 8.2±7.6 years; p=0.002). Comparing to ≤3 years usage, prolonged consumption of oral contraceptive for ≥10 years reduced the risk of CIN (p=0.012). However, use of condom for contraception might not be associated with a reduced risk of CIN after accounting for the effects of confounding factors (adjusted OR, 0.52; 95% CI, 0.05 to 5.11; p=0.577).
Conclusion: Use of oral contraceptives, but not condoms, for contraception appeared to be inversely associated with CIN. Prolonged use of oral contraceptive demonstrated its benefits of reducing the risk of CIN.

참고문헌 (Reference)

1 Gavric-Lovrec V, "Use of various contraceptives and human papillomavirus 16 and 18 infections in women with cervical intraepithelial neoplasia" 21 : 424-427, 2010

2 Grimbizis GF, "The use of hormonal contraception and its protective role against endometrial and ovarian cancer" 24 : 29-38, 2010

3 Guven S, "The underlying cause of cervical cancer in oral contraceptive users may be related to cervical mucus changes" 69 : 550-552, 2007

4 Rieck G, "The effect of lifestyle factors on gynaecological cancer" 20 : 227-251, 2006

5 Kjellberg L, "Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection" 82 : 1332-1338, 2000

6 Gadducci A, "Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis:a review of the literature" 27 : 597-604, 2011

7 Ma LT, "Should highrisk adolescents have Papanicolaou tests?" 121 : 432-439, 2013

8 National Health and Medical Research Council, "Screening to prevent cervical cancer: guidelines for the management of asymptomatic women with screen detected abnormalities"

9 Moscicki AB, "Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females" 285 : 2995-3002, 2001

10 Moscicki AB, "Risks for cervical intraepithelial neoplasia 3 among adolescents and young women with abnormal cytology" 112 : 1335-1342, 2008

11 Maria Pasalich, "Reproductive factors for ovarian cancer in southern Chinese women" 대한부인종양학회 24 (24): 135-140, 2013

12 Syrjanen K, "Oral contraceptives are not an independent risk factor for cervical intraepithelial neoplasia or high-risk human papillomavirus infections" 26 (26): 4729-4740, 2006

13 Frega A, "Oral contraceptives and clinical recurrence of human papillomavirus lesions and cervical intraepithelial neoplasia following treatment" 100 : 175-178, 2008

14 Miller K, "Oral contraceptives and cervical cancer: critique of a recent review" 69 : 347-351, 2004

15 Samir R, "Oral contraceptive and progestin-only use correlates to tissue tumor marker expression in women with cervical intraepithelial neoplasia" 85 : 288-293, 2012

16 Webberley H, "Oral contraception" 13 : 21-29, 2003

17 Richardson H, "Modifiable risk factors associated with clearance of type-specific cervical human papillomavirus infections in a cohort of university students" 14 : 1149-1156, 2005

18 Munk AC, "Interaction of epithelial biomarkers, local immune response and condom use in cervical intraepithelial neoplasia 2-3 regression" 127 : 489-494, 2012

19 Schneider HP, "IARC monographs program on carcinogenicity of combined hormonal contraceptives and menopausal therapy" 8 : 311-316, 2005

20 Green J, "Human papillomavirus infection and use of oral contraceptives" 88 : 1713-1720, 2003

21 Kim J, "Human papillomavirus genotypes and cofactors causing cervical intraepithelial neoplasia and cervical cancer in Korean women" 22 : 1570-1576, 2012

22 Longatto-Filho A, "Hormonal contraceptives and the length of their use are not independent risk factors for highrisk HPV infections or high-grade CIN" 71 : 93-103, 2011

23 Coker AL, "Hormonal and barrier methods of contraception, oncogenic human papillomaviruses, and cervical squamous intraepithelial lesion development" 10 : 441-449, 2001

24 Folger SG, "Guidance on medical eligibility criteria for contraceptive use:identification of research gaps" 82 : 113-118, 2010

25 World Cancer Research Fund, "Food, nutrition, physical activity, and the prevention of cancer: a global perspective" American Institute for Cancer Research 2007

26 Monsonego J, "Estrogen and progesterone receptors in cervical human papillomavirus related lesions" 48 : 533-539, 1991

27 Schmeink CE, "Effect of the menstrual cycle and hormonal contraceptives on human papillomavirus detection in young, unscreened women" 116 : 67-75, 2010

28 Kazerooni T, "Does contraceptive method change the Pap smear finding?" 66 : 243-246, 2002

29 Harris TG, "Depot-medroxyprogesterone acetate and combined oral contraceptive use and cervical neoplasia among women with oncogenic human papillomavirus infection" 200 : 489.e1-489.e8, 2009

30 Schiff M, "Contraceptive and reproductive risk factors for cervical intraepithelial neoplasia in American Indian women" 29 : 983-990, 2000

31 Read C, "Contraception and pregnancy then and now: examining the experiences of a cohort of mid-age Australian women" 49 : 429-433, 2009

32 Smith JS, "Cervical cancer and use of hormonal contraceptives: a systematic review" 361 : 1159-1167, 2003

33 Parazzini F, "Barrier methods of contraception and the risk of cervical neoplasia" 40 : 519-530, 1989